PCM Encore »

Alnylam Pharmaceuticals shares owned by PCM Encore

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by PCM Encore from 13F filings

Historical chart of PCM Encore investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by PCM Encore consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by PCM Encore

Quarter filed Position value Share count Share price at filing
2026-03-31 $215k 651 330.75

More positions owned by PCM Encore

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Russell 2000 Etf (IWM)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Exxon Mobil Corporation (XOM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for PCM Encore

Top funds holding Alnylam Pharmaceuticals

FMR
Vanguard Group
Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Two Sigma Investments
Dodge & Cox
T. Rowe Price Investment Management
Wellington Management Company
American Century Companies

View all funds holding Alnylam Pharmaceuticals